Bowland S L, Shewen P E
Department of Pathobiology, Ontario Veterinary College, University of Guelph.
Can Vet J. 2000 Jan;41(1):33-48.
Bovine respiratory disease (BRD) remains a significant cost to both the beef and dairy industries. In the United States, an estimated 640 million dollars is lost annually due to BRD. Losses are largely a result of pneumonic pasteurellosis ("shipping fever"), enzootic pneumonia of calves, and atypical interstitial pneumonia. In Canada, over 80% of the biologics licensed for use in cattle are against agents associated with BRD. The objectives of this paper were (a) to summarize information available concerning commercial vaccines currently used in Canada for protection against BRD, and (b) to provide an easily accessible resource for veterinary practitioners and researchers. Information from the most recent Compendium of Veterinary Products has been tabulated for each vaccine by trade name, according to vaccine type, and the pathogens against which they are designed to protect. Additional information from published articles (peer-reviewed and other) has been provided and referenced.
牛呼吸道疾病(BRD)仍然是牛肉和乳制品行业的一项重大成本。在美国,估计每年因BRD损失6.4亿美元。损失主要是由肺炎巴氏杆菌病(“运输热”)、犊牛地方流行性肺炎和非典型间质性肺炎造成的。在加拿大,超过80%的获准用于牛的生物制品是针对与BRD相关的病原体的。本文的目的是:(a)总结加拿大目前用于预防BRD的商业疫苗的现有信息,以及(b)为兽医从业者和研究人员提供一个易于获取的资源。已根据疫苗类型和它们旨在预防的病原体,按商品名将最新的《兽药产品手册》中的信息制成表格,列出了每种疫苗的相关信息。还提供并引用了已发表文章(同行评审文章和其他文章)中的其他信息。